Clinical Trial Update: Boronophenylalanine (BPA)-Based Boron Neutron Capture Therapy (BNCT) in the Treatment Head and Neck Tumors [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/Phase 2 clinical trial evaluating boronophenylalanine-based boron neutron capture therapy (BNCT) for head and neck cancers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Boronophenylalanine (BPA) (boronophenylalanine)

Snippet

Sponsor: Boneca Corporation | Conditions: Head and Neck Cancer | Phase 1, Phase 2 | Status: COMPLETED